1.Current Status and Future Clinical Applications of Array.based Comparative Genomic Hybridization.
Genomics & Informatics 2004;2(3):113-120
No abstract available.
Chromosome Aberrations
;
Comparative Genomic Hybridization*
2.Copy Number Variations in the Human Genome: Potential Source for Individual Diversity and Disease Association Studies.
Tae Min KIM ; Seon Hee YIM ; Yeun Jun CHUNG
Genomics & Informatics 2008;6(1):1-7
The widespread presence of large-scale genomic variations, termed copy number variation (CNVs), has been recently recognized in phenotypically normal individuals. Judging by the growing number of reports on CNVs, it is now evident that these variants contribute significantly to genetic diversity in the human genome. Like single nucleotide polymorphisms (SNPs), CNVs are expected to serve as potential biomarkers for disease susceptibility or drug responses. However, the technical and practical concerns still remain to be tackled. In this review, we examine the current status of CNV DBs and research, including the ongoing efforts of CNV screening in the human genome. We also discuss the characteristics of platforms that are available at the moment and suggest the potential of CNVs in clinical research and application.
Coat Protein Complex I
;
Disease Susceptibility
;
Genetic Variation
;
Genome, Human
;
Humans
;
Mass Screening
;
Polymorphism, Single Nucleotide
;
Biomarkers
3.Copy Number Variations in the Human Genome: Potential Source for Individual Diversity and Disease Association Studies.
Tae Min KIM ; Seon Hee YIM ; Yeun Jun CHUNG
Genomics & Informatics 2008;6(1):1-7
The widespread presence of large-scale genomic variations, termed copy number variation (CNVs), has been recently recognized in phenotypically normal individuals. Judging by the growing number of reports on CNVs, it is now evident that these variants contribute significantly to genetic diversity in the human genome. Like single nucleotide polymorphisms (SNPs), CNVs are expected to serve as potential biomarkers for disease susceptibility or drug responses. However, the technical and practical concerns still remain to be tackled. In this review, we examine the current status of CNV DBs and research, including the ongoing efforts of CNV screening in the human genome. We also discuss the characteristics of platforms that are available at the moment and suggest the potential of CNVs in clinical research and application.
Coat Protein Complex I
;
Disease Susceptibility
;
Genetic Variation
;
Genome, Human
;
Humans
;
Mass Screening
;
Polymorphism, Single Nucleotide
;
Biomarkers
4.Introduction of Relative Survival Analysis Program: Using Sample of Cancer Registry Data with Stata Software.
Kyu Won JUNG ; Hyun Joo KONG ; Seon Hee YIM ; Young Joo WON ; Joohon SUNG ; Hai Rim SHIN
Korean Journal of Epidemiology 2007;29(2):222-229
Patient survival is one of the most important measures for the evaluation of progress in cancer patient care across the wide spectrum from diagnosis to treatment. The optimal monitoring method for cancer patient survival is to estimate survival based on representative data from cancer patients in the population, which is only achievable through using population-based cancer registration data. Relative survival is used to compare the survival experience in a study cohort that expected to result from background population mortality rates. This technique is useful when the cause of death is not accurate or not available, since it provides a measure of excess mortality in a group of patients with a certain disease. The purpose of this article is to demonstrate the procedures for estimating relative survival using the statistical software Stata. For this survival analysis to show the procedure, the example data set was randomly selected from the National Cancer Incidence Database, which was used in a recent article reporting the overall relative survival of cancer patients diagnosed during 1993-2002 in Korea.
Cause of Death
;
Cohort Studies
;
Dataset
;
Diagnosis
;
Humans
;
Incidence
;
Korea
;
Mortality
;
Patient Care
;
Survival Analysis*
5.Primary omental yolk sac tumor.
Seon Hwa LIM ; Yon Hee KIM ; Ga Won YIM ; Eun Ji NAM ; Young Tae KIM ; Sunghoon KIM
Obstetrics & Gynecology Science 2013;56(6):412-415
Extra-ovarian yolk sac tumor arising in the omentum is extremely rare. As yolk sac tumor originated from the omentum has been rarely reported, its clinical information is very limited. The authors encountered a case of yolk sac tumor originated from the omentum, and reported the case herein. A 32-year-old woman was presented with developed low abdominal distension for a month. Magnetic resonance imaging findings were suggestive of ovarian malignancy with ascites and peritoneal seeding nodules. Explorative laparotomy was performed and then the findings from frozen biopsy of omentum were suggestive of poorly differentiated tumor though whether it was primary or metastatic was uncertain. Thus, staging laparotomy were performed. Histopathology confirmed that the tumor was a yolk sac tumor of omentum origin. Then, 6 cycles of postoperative adjuvant chemotherapy at intervals of 3 weeks were performed using bleomycin, etoposide, and cisplatin regimen. Four-year outpatient follow-up thereafter showed no relapse.
Adult
;
Ascites
;
Biopsy
;
Bleomycin
;
Chemotherapy, Adjuvant
;
Cisplatin
;
Endodermal Sinus Tumor*
;
Etoposide
;
Female
;
Follow-Up Studies
;
Humans
;
Laparotomy
;
Magnetic Resonance Imaging
;
Omentum*
;
Outpatients
;
Rare Diseases
;
Yolk Sac
6.Introduction to International Ethical Standards Related to Genetics and Genomics.
Genomics & Informatics 2013;11(4):218-223
The rapid advances in genetic knowledge and technology raise various, sometimes unprecedented, ethical dilemmas in the scientific community as well as the public realm. To deal with these dilemmas, the international community has prepared and issued ethical standards in various formats. In this review, seven international standards regarding genetics and genomics will be briefly introduced in chronological order. Critical reflections on them will not be provided in this review, and naturally, they have their own problems and shortcomings. However, a common set of the principles expressed in them will be highlighted here, because they are still relevant, and many of them will be more relevant in the future. Some of the interesting contents will be selected and described. After that, the morality of one recent event related to whole-genome sequencing and person-identifiable genetic data will be explored based on those international standards.
Ethics
;
Genetics*
;
Genomics*
;
Morals
7.Clinical implications of copy number variations in autoimmune disorders.
Seon Hee YIM ; Seung Hyun JUNG ; Boram CHUNG ; Yeun Jun CHUNG
The Korean Journal of Internal Medicine 2015;30(3):294-304
Human genetic variation is represented by the genetic differences both within and among populations, and most genetic variants do not cause overt diseases but contribute to disease susceptibility and influence drug response. During the last century, various genetic variants, such as copy number variations (CNVs), have been associated with diverse human disorders. Here, we review studies on the associations between CNVs and autoimmune diseases to gain some insight. First, some CNV loci are commonly implicated in various autoimmune diseases, such as Fcgamma receptors in patients with systemic lupus erythemoatosus or idiopathic thrombocytopenic purpura and beta-defensin genes in patients with psoriasis or Crohn's disease. This means that when a CNV locus is associated with a particular autoimmune disease, we should examine its potential associations with other diseases. Second, interpopulation or interethnic differences in the effects of CNVs on phenotypes exist, including disease susceptibility, and evidence suggests that CNVs are important to understand susceptibility to and pathogenesis of autoimmune diseases. However, many findings need to be replicated in independent populations and different ethnic groups. The validity and reliability of detecting CNVs will improve quickly as genotyping technology advances, which will support the required replication.
Animals
;
Autoimmune Diseases/ethnology/*genetics/immunology
;
Autoimmunity/*genetics
;
*DNA Copy Number Variations
;
*Gene Dosage
;
Genetic Association Studies
;
Genetic Markers
;
Genetic Predisposition to Disease
;
Humans
;
Phenotype
;
Population Groups/genetics
;
Risk Factors
8.A Case of Generalized Syringoma Misdiagnosed as Verruca Plana.
Seon Mi YIM ; Sang Min KIM ; Young Chan SONG ; Sang Hee LIM ; Yang Won LEE ; Kyu Joong AHN
Korean Journal of Dermatology 2006;44(12):1441-1443
Generalized syringoma is a rare variant of syringoma, whose incidence peaks during childhood and adolescence, with no difference seen in either sex. It frequently affects the chest, neck, abdomen and axilla, and occasionally shows spontaneous regression. A 34-year-old woman presented with pruritic, multiple, 1~3 mm sized, lightbrownish papules on the chest, abdomen, and back. One year before, she had been diagnosed as having verruca plana at a private dermatologic clinic and had received immunotherapy, but experienced disappointing results. Histologically, the disorder showed numerous dilated eccrine ducts lined by two rows of epithelial cells. We herein report a case of generalized syringoma misdiagnosed as verruca plana, plus a review of the literature.
Abdomen
;
Adolescent
;
Adult
;
Axilla
;
Diagnostic Errors
;
Epithelial Cells
;
Female
;
Humans
;
Immunotherapy
;
Incidence
;
Neck
;
Syringoma*
;
Thorax
;
Warts*
9.A Case of Localized Scleroderma Treated with Low-dose UVA1 Phototherapy.
Sang Hee LIM ; Seon Mi YIM ; Min Woo LEE ; Yang Won LEE ; Yong Beom CHOE ; Kyu Joong AHN
Korean Journal of Dermatology 2006;44(4):474-478
Localized scleroderma is a form of connective tissue disease in which the normally soft-textured surface of the skin hardens due to deposition of collagen within the dermis. Recently, UVA1 phototherapy with shorter wavelength in the UVA2 region has been shown to have excellent effect in the treatment of scleroderma, including systemic sclerosis. Here, we report a case of a 57 year-old female with linear scleroderma and manifestation of Raynaud's phenomenon who showed marked improvement after 13 sessions of whole body therapy with low dose UVA1. Ultrasound scanning and skin elasticity measurement were taken to evaluate therapeutic effectiveness of UVA1 phototherapy.
Collagen
;
Connective Tissue Diseases
;
Dermis
;
Elasticity
;
Female
;
Humans
;
Middle Aged
;
Phototherapy*
;
Scleroderma, Localized*
;
Scleroderma, Systemic
;
Skin
;
Ultrasonography
10.Role of Corticotrophin-releasing Factor in the Stress-induced Dilation of Esophageal Intercellular Spaces.
Young Ju CHO ; Jang Hee KIM ; Hyun Ee YIM ; Da Mi LEE ; Seon Kyo IM ; Kwang Jae LEE
Journal of Korean Medical Science 2011;26(2):279-283
Corticotrophin-releasing factor (CRF) plays a major role in coordinating stress responses. We aimed to test whether blocking endogenous CRF activity can prevent the stress-induced dilation of intercellular spaces in esophageal mucosa. Eighteen adult male rats were divided into 3 groups: 1) a non-stressed group (the non-stressed group), 2) a saline-pretreated stressed group (the stressed group), 3) and an astressin-pretreated stressed group (the astressin group). Immediately after completing the experiments according to the protocol, distal esophageal segments were obtained. Intercellular space diameters of esophageal mucosa were measured by transmission electron microscopy. Blood was sampled for the measurement of plasma cortisol levels. Mucosal intercellular spaces were significantly greater in the stressed group than in the non-stressed group. Mucosal intercellular spaces of the astressin group were significantly smaller than those of the stressed group. Plasma cortisol levels in the stressed group were significantly higher than in the non-stressed group. Pretreatment with astressin tended to decrease plasma cortisol levels. Acute stress in rats enlarges esophageal intercellular spaces, and this stress-induced alteration appears to be mediated by CRF. Our results suggest that CRF may play a role in the pathophysiology of reflux-induced symptoms or mucosal damage.
Animals
;
Corticotropin-Releasing Hormone/*antagonists & inhibitors/metabolism/pharmacology
;
Esophagus/anatomy & histology/*drug effects
;
Extracellular Space/*drug effects
;
Hydrocortisone/blood
;
Male
;
Mucous Membrane/anatomy & histology/*drug effects
;
Neuroprotective Agents/pharmacology
;
Peptide Fragments/*pharmacology
;
Rats
;
Rats, Wistar
;
*Stress, Psychological/blood/physiopathology